Replimune Group, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76029N1063
USD
7.71
-2.47 (-24.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryReplimune Group, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-24.26%
0.03%
1W
-19.94%
-0.35%
1M
0%
0.08%
YTD
-36.33%
1.02%
1Y
-14.33%
13.02%
3Y
-50.45%
72.04%
5Y
-63.67%
80.03%
10Y
-63.67%
262.66%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-30.79%
0%
-30.79%
6 Months
-39.95%
0%
-39.95%
1 Year
-14.33%
0%
-14.33%
2 Years
-65.69%
0%
-65.69%
3 Years
-50.45%
0%
-50.45%
4 Years
-76.7%
0%
-76.7%
5 Years
-63.67%
0%
-63.67%

Replimune Group, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary